CSYX:XETRA:XETRA-Credit Suisse Index Fund (IE) ETF ICAV - CSIF (IE) DAX 50 ESG Blue UCITS ETF B EUR Acc (EUR)

ETF | Others |

Last Closing

USD 9.981

Change

0.00 (0.00)%

Market Cap

USD 1.79M

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.06 (+0.11%)

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.02 (+0.13%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.01 (+0.02%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.02 (+0.06%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.04 (+0.15%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-0.18 (-0.12%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

+0.07 (+0.15%)

USD 102.57B
8R80:XETRA Amundi Index Solutions - Amund..

+0.80 (+0.57%)

USD 102.14B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.05 (+0.09%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.60 (-0.12%)

USD 80.38B

ETFs Containing CSYX:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain -0.04% 19% F 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.04% 19% F 26% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.96% 59% D- 58% F
Dividend Return 5.96% 58% F 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.12% 69% C- 76% C+
Risk Adjusted Return 73.42% 90% A- 90% A-
Market Capitalization 1.79M 1% F 1% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.